COVID-19 infections jumped 30% in a week, with 70% of new cases caused by subvariants BQ.1 and BQ.1.1. Those variants are resistant to some monoclonal antibody treatments, causing the FDA to withdraw authorization for bebtelovimab, leaving the new boosters as the best hope for preventing severe illness. Meanwhile influenza case numbers are shattering records, with rates nearly doubling the highest recorded in the past 8 years.
Source: pennnews
Pennsylvania COVID update: Weekly cases jump 30% to 13,936 as a monoclonal treatment proves ineffective against new variants and flu rates soar
More from NewsMore posts in News »
- Lobbyist says she was harassed by current Pa. lawmaker, wants legislature to change misconduct rules
- Paul Muschick: Pa. House closed for business, but lawmakers still getting paid. Here’s how much gridlock is costing taxpayers.
- How Pennsylvania homeowners can apply for mortgage and utility assistance
- Hopes of bipartisan cooperation give way to complete deadlock in the Pa. House
You must be logged in to post a comment.